"The Indian pharmaceutical market for chronic diseases is experiencing significant growth. By leveraging our expertise in chronic therapies and dedication to innovation and brand development, JB Pharma is well-positioned to continue its upward trajectory in the Indian pharmaceutical market." - Dilip Singh Rathore, President-India Business, JB Pharma
Read More
Abbott's XIENCE Sierra stent represents a significant evolution in this field, having an expanded expansion range and high longitudinal strength, ensuring stability and minimising risks during the procedure
Read More
Concurrently, liver diseases, are emerging as significant comorbidities, affecting up to 25 per cent of the global population
Read More_20240430161108original_image_28.webp)
The initiative, titled "Walk for Parkinson's," brought together individuals, experts, and healthcare professionals to shed light on the challenges faced by those battling this neurological disorder
Read More
Recognising the critical role of vaccination in safeguarding individual and community health, the program underscores the importance of routine immunisation in preventing vaccine-preventable diseases and enhancing overall immunity
Read More
